Enimmune corporation Company Description

Enimmune corporation operates as a biopharmaceutical Research and development, and marketing company in Taiwan.

Its products include Tuberculin PPD RT23 SSI, an approved drug for tuberculin test to determine whether the patient is infected with tuberculosis.

The company is also involved in the development of vaccines to prevent various infectious diseases, such as enterovirus, pneumonia, norovirus, dengue fever virus, Middle East respiratory syndrome coronavirus, etc. Enimmune corporation was founded in 2014 and is based in Taichung City, Taiwan.

Enimmune corporation

Country	Taiwan
Founded	2014
Industry	Biotechnology
Sector	Healthcare
CEO	Zhe Wei Zhang

Contact Details

Address: No. 3, Section 1 Taichung City Taiwan
Phone	886 4 2536 0925
Website	enimmune.com.tw

Stock Details

Ticker Symbol	6564
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006564008
SIC Code	2836

Key Executives

Name	Position
Zhe Wei Zhang	Chief Executive Officer